Brief: Hologic Q4 Adjusted EBITDA USD 347 Million Vs. IBES Estimate USD 346.1 Million
Nov 03 (Reuters) - Hologic Q4 revenue USD 1,049.5 million vs. IBES estimate USD 1,034 million. Q4 EPS USD 0.83 Q4 adjusted EPS USD 1.13 vs. IBES estimate USD 1.1 Q4 adjusted gross margin 60.9% Q4 adjusted net income USD 254.7 million vs. IBES estimate USD 246.1 million
Recent news on Hologic
See all newsBrief: Blackstone And Tpg Complete Acquisition Of Hologic
Casey's General Stores edges higher ahead of replacing Hologic in S&P 500
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Says Casey's General Stores Inc. Will Replace Hologic Inc. In The S&P 500 Effective Prior To The Market Open On April 9